Back
Cassava Sciences Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
28
SAVA
Cassava Sciences
Last Price:
27.06
Seasonality Move:
4.31%
Sell
41
VRTX
Vertex Pharmaceuticals
Last Price:
455.34
Seasonality Move:
5.22%
Sell
28
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $27.08. The Score for SAVA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- SAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $455.31. The Score for VRTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $27.08
The current trend is moderately bearish and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $455.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight selling pressure.
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 46.8 | Sell |
| Chaikin Money Flow: | -673856 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.15 - 30.11) | Sell |
| Bollinger Bands (100): | (15.7 - 29.08) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.49 | Sell |
| Relative Strength Index (14 RSI): | 38.19 | Sell |
| Chaikin Money Flow: | -19753 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (460.67 - 481.05) | Sell |
| Bollinger Bands (100): | (458.48 - 489.66) | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.59 | Sell |
| 20-day SMA: | 28.65 | Sell |
| 50-day SMA: | 27.55 | Sell |
| 200-day SMA: | 22.56 | Buy |
| 8-day EMA: | 28 | Sell |
| 20-day EMA: | 28.36 | Sell |
| 50-day EMA: | 26.55 | Buy |
| 200-day EMA: | 23.18 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 461.71 | Sell |
| 20-day SMA: | 469.24 | Sell |
| 50-day SMA: | 476.71 | Sell |
| 200-day SMA: | 444.79 | Buy |
| 8-day EMA: | 461.33 | Sell |
| 20-day EMA: | 467.3 | Sell |
| 50-day EMA: | 472 | Sell |
| 200-day EMA: | 442.99 | Buy |
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.97 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.
Cassava Sciences Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||